Primary information |
---|
ID | 20726 |
Pubchem ID | NA |
Name | Lipoxin B4 |
Description | Lipoxins (LXs) and aspirin-triggered lipoxin (ATL) are trihydroxytetraene-containing eicosanoids generated from arachidonic acid that are distinct in structure; formation; and function from the many other proinflammatory lipid-derived mediators. |
Synonym | (5S;14R;6E;8Z;10E;12E;15S)-5;14;15-Trihydroxy-6;8;10;12-eicosatetraenoic acidChEBI(5S;6E;8Z;10E;12E;14R;15S)-5;14;15-Trihydroxyeicosa-6;8;10;12-tetraenoic acidChEBI(6E;8Z;10E;12E)-(5S;14R;15S)-Trihydr |
Molecular Weight | 352.4651 |
Formula | NA |
IUPAC | (5S;6E;8Z;10E;12E;14R;15S)-5;14;15-trihydroxyicosa-6;8;10;12-tetraenoic acid |
SMILE | CCCCC[C@H](O)[C@H](O)C=CC=CC=C/C=C/[C@@H](O)CCCC(O)=O |
PDB ID | NA |
KEGG | C06315 |
HMDB ID | HMDB0005082 |
Melting Point (Degree C) | NA |
Water Solubility | NA |
Drugbank ID | NA |
Receptor | NA |
Reference | HMDB
|